Author

F. Zandkarimi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

B. R. Stockwell· 2 shared A. A. Saleh· 1 shared A. Dovas· 1 shared A. Lim· 1 shared A. M. Decker· 1 shared A. Mahajan· 1 shared A. Razavilar· 1 shared A. Sivan· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. R. Stockwell

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Colorectal cancer detection and treatment with engineered probiotics

C. R. Gurbatri, G. Radford, L. Vrbanac, C. Coker, J. Im, S. R. Taylor, Y. Jang, A. Sivan, K. Rhee, A. A. Saleh, T. Chien, F. Zandkarimi, I. Lia, T. R. Lannagan, T. Wang, , T. Danino

This paper demonstrates the use of engineered probiotics to detect and treat colorectal cancer by monitoring their colonization and delivering therapeutic molecules.

bioRxiv · Apr 3, 2023 · PreprintBioengineering

A cell state specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma

M. A. Banu, A. Dovas, M. G. Argenziano, W. Zhao, H. Cuervo, D. M. Higgins, C. P. Sperring, B. Pereira, L. F. Ye, A. Mahajan, N. Humala, J. L. Furnari, P. S. Upadhyayula, F. Zandkarimi, T. T. Nguyen, , P. D. Canoll

The paper identifies a metabolic vulnerability in specific glioma cell states that can be targeted with GPX4 inhibitors to induce ferroptosis.

bioRxiv · Feb 22, 2023Cancer Biology

Multimodal mass spectrometry imaging reveals single-cell metabolic states in mammalian liver

H. Tian, P. R. Rajbhandari, J. Tarolli, A. M. Decker, T. V. Neelakantan, T. Angerer, F. Zandkarimi, J. Daniels, H. R. Remotti, G. Frache, N. Winograd, B. R. Stockwell

This paper develops a multimodal mass spectrometry imaging workflow to classify liver cell types and metabolic zones at single-cell resolution in human tissue.

bioRxiv · Sep 26, 2022 · PreprintCell Biology